Recover more revenue from denied insurance claims.

~12 to 19%

national denial benchmarks in third party and federal transparency data. The exact share depends on payer, product, and what is counted as a denial.

11.81% initial denial rate in a multi hospital / multi physician Kodiak Revenue Cycle Analytics release (Business Wire, May 21, 2025; calendar 2024 activity). 19% of in network claims denied on federally reported HealthCare.gov qualified health plans: KFF analysis of CMS Marketplace transparency (Mar 24, 2026; 2024 coverage year).

~10%

of denied Medicare Advantage prior authorization decisions in 2022 CMS filings were appealed, and most appeals that were filed succeed, so seldom appealing leaves money on the table.

Summarized by AMA (Oct 3, 2024) from KFF’s review of Medicare Advantage prior authorization data reported to CMS (roughly 2019 to 2022). Distinct cohort: fewer than 1% of federally reported Marketplace in network denied claims had an internal appeal in 2024 per KFF’s CMS Marketplace analysis cited above.

76%

of hospital CFOs / revenue cycle leaders included denials management when asked to pick their most time consuming RCM tasks (respondents could select up to five).

Commissioned AKASA survey fielded via HFMA Pulse Survey; 556 U.S. hospital CFO / revenue cycle leaders, Jul 8 to Aug 2 2022; press summary Apr 19, 2023 (akasa.com/press/).